Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Metastatic Castration-resistant Prostate Cancer × Pluvicto × Clear all

Phase

Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castrate Resistant Prostate Cancer (mCRPC) 1 Glioma 1 Glioblastoma 1 Disease 1 Astrocytoma 1

Interventions

Nivolumab 2 radium Ra 223 dichloride 1 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 darolutamide 1 cabozantinib 1 bempegaldesleukin 1 Radium-223 1 Radiosurgery 1 Pluvicto 1 Cyclophosphamide 1 Blood Specimen Collection 1 Abiraterone Acetate 1 177Lu-EB-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05613894 2025-10-31

CaboLu

University of Utah

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡